Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUB
1451
DELISTED
Cubic Corporation
CUB
| $21.9M | ﹤0.01% |
456,348
+15,345
| +3% | +$624K |
|
1452
SITE Centers
SITC
$164M
| $21.9M | ﹤0.01% |
3,467,909
+523,029
| +18% | +$2.56M |
|
|
VISN
1453
Vistance Networks Inc
VISN
$2.33B
| $21.9M | ﹤0.01% |
2,627,525
+258,325
| +11% | +$2.55M |
|
|
ADVM
1454
DELISTED
Adverum Biotechnologies
ADVM
| $21.9M | ﹤0.01% |
104,708
+13,761
| +15% | +$2.44M |
|
|
ARNC
1455
DELISTED
Arconic Corporation
ARNC
| $21.8M | ﹤0.01% |
+1,565,172
| New | +$18.3M |
|
|
AQUA
1456
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $21.7M | ﹤0.01% |
1,168,509
+85,616
| +8% | +$1.42M |
|
1457
Adient
ADNT
$1.45B
| $21.7M | ﹤0.01% |
1,320,047
+23,274
| +2% | +$354K |
|
1458
Thomson Reuters
TRI
$43.4B
| $21.7M | ﹤0.01% |
303,719
-12,778
| -4% | -$924K |
|
1459
WSFS Financial
WSFS
$4.17B
| $21.7M | ﹤0.01% |
755,217
-18,594
| -2% | -$492K |
|
|
ITCI
1460
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $21.6M | ﹤0.01% |
843,024
+36,422
| +5% | +$737K |
|
1461
CareDx
CDNA
$2.32B
| $21.6M | ﹤0.01% |
609,706
+27,997
| +5% | +$797K |
|
|
LMNX
1462
DELISTED
Luminex Corp
LMNX
| $21.6M | ﹤0.01% |
662,842
+1,450
| +0.2% | +$45.9K |
|
1463
Atkore
ATKR
$3.16B
| $21.6M | ﹤0.01% |
788,130
+581
| +0.1% | +$14.4K |
|
|
FIT
1464
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $21.6M | ﹤0.01% |
3,337,020
+23,491
| +0.7% | +$153K |
|
|
TRTN
1465
DELISTED
Triton International Limited
TRTN
| $21.5M | ﹤0.01% |
711,831
-7,616
| -1% | -$226K |
|
|
PS
1466
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $21.5M | ﹤0.01% |
1,192,550
+281,289
| +31% | +$4.76M |
|
1467
BCE
BCE
$21.2B
| $21.5M | ﹤0.01% |
465,304
+1,276
| +0.3% | +$52.5K |
|
1468
Comfort Systems
FIX
$60.3B
| $21.4M | ﹤0.01% |
525,412
+12,823
| +3% | +$456K |
|
1469
Macerich
MAC
$6.66B
| $21.2M | ﹤0.01% |
2,366,372
+476,926
| +25% | +$3.69M |
|
1470
Mueller Water Products
MWA
$4.24B
| $21.2M | ﹤0.01% |
2,248,123
+59,964
| +3% | +$537K |
|
1471
Forward Air
FWRD
$601M
| $21.2M | ﹤0.01% |
425,036
+11,641
| +3% | +$571K |
|
1472
Schrodinger
SDGR
$1.33B
| $21.1M | ﹤0.01% |
230,912
+149,924
| +185% | +$8.73M |
|
1473
Spectrum Brands
SPB
$2.03B
| $21.1M | ﹤0.01% |
459,340
-32,644
| -7% | -$1.39M |
|
1474
Pediatrix Medical
MD
$2.15B
| $21M | ﹤0.01% |
1,229,074
+269,068
| +28% | +$3.99M |
|
1475
First Bancorp
FBP
$4.44B
| $21M | ﹤0.01% |
3,752,809
+209,446
| +6% | +$1.14M |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.